Although companies often need to develop clinical trial transparency programs to meet regulations, it can be unclear where to start. How should you create a compliant transparency program? Join Darshan Kulkarni as he talks with guest Major Hoffman...
Creating an effective clinical trial transparency program can be difficult. What should your company consider before developing a transparency strategy? Join Darshan Kulkarni as he talks about how to successfully create a transparency strategy that...
Clinical study transparency programs are necessary for companies looking to disclose data and fully comply with state and federal regulations. Why else should your company create a transparency program? Join Darshan Kulkarni as he talks with guest...
Due to Brexit, the Medicines and Healthcare products Regulatory Agency (MHRA) has had to develop its own procedures separate from the European Medicines Agency (EMA). What new guidance has the MHRA released? Join Darshan Kulkarni as he talks with...
There is growing pressure being placed on pharmaceutical companies to make their clinical trials more transparent. Despite this pressure, there remain privacy concerns about publicizing clinical research data. How can companies successfully balance...
Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
